Haleon plc is a consumer healthcare company. The Companyâs product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Companyâs geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Companyâs oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļHLN
āļāļ·āđāļāļāļĢāļīāļĐāļąāļHaleon PLC
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJul 18, 2022
āļāļĩāļāļĩāđāļMcnamara (Brian)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ- -
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒDepository Receipt
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļJul 18
āļāļĩāđāļāļĒāļđāđBuilding 5, First Floor
āđāļĄāļ·āļāļWEYBRIDGE
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited Kingdom
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđKT13 0NY
āđāļāļĢāļĻāļąāļāļāđ441932822000
āđāļ§āđāļāđāļāļāđhttps://www.haleon.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļHLN
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJul 18, 2022
āļāļĩāļāļĩāđāļMcnamara (Brian)
Ms. Lisa Paley
President, North America
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
Dame Vivienne Cox
Non-Executive Independent Director
Non-Executive Independent Director
Ms. Asmita Dubey
Non-Executive Independent Director
Non-Executive Independent Director
Ms. Amanda J. Mellor
Company Secretary
Mr. Keith Choy
President, Asia Pacific
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Ms. Lisa Paley
President, North America
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
Ms. Marie-Anne Aymerich
Non-Executive Independent Director
Non-Executive Independent Director
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
Mr. Manvinder Singh S. Banga ,
Mr. Manvinder Singh S. Banga ,
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
VanEck Pharmaceutical ETF
Franklin ClearBridge Enhanced Income ETF
ActivePassive International Equity ETF
SP Funds S&P World (ex-US) ETF
Avantis Responsible International Equity ETF
Avantis International Equity ETF
Avantis International Large Cap Value ETF
Unusual Whales Subversive Democratic Trading ETF
Fidelity Blue Chip Value ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
VanEck Pharmaceutical ETF
āļŠāļąāļāļŠāđāļ§āļ6.34%
Franklin ClearBridge Enhanced Income ETF
āļŠāļąāļāļŠāđāļ§āļ1.87%
One Global ETF
āļŠāļąāļāļŠāđāļ§āļ0.65%
ActivePassive International Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.33%
SP Funds S&P World (ex-US) ETF
āļŠāļąāļāļŠāđāļ§āļ0.27%
Avantis Responsible International Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.13%
Avantis International Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.08%
Avantis International Large Cap Value ETF
Unusual Whales Subversive Democratic Trading ETF
Fidelity Blue Chip Value ETF
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
570.00M
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
HLN.NB Approximate final Cash Dividend of gross USD 0.130732 paid on May 14, 2026 going ex on Apr 10, 2026
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
HLN.NB Interim Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
HLN.NB Final Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023